4/22
08:07 am
vvos
Vivos Therapeutics (VVOS) had its price target lowered by Ascendiant Capital Markets from $5.50 to $3.00. They now have a "buy" rating on the stock.
Low
Report
Vivos Therapeutics (VVOS) had its price target lowered by Ascendiant Capital Markets from $5.50 to $3.00. They now have a "buy" rating on the stock.
4/22
06:09 am
vvos
Vivos Therapeutics (VVOS) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
Low
Report
Vivos Therapeutics (VVOS) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
4/17
10:56 am
vvos
Vivos Therapeutics (VVOS) had its price target lowered by HC Wainwright from $7.00 to $2.50. They now have a "buy" rating on the stock.
Medium
Report
Vivos Therapeutics (VVOS) had its price target lowered by HC Wainwright from $7.00 to $2.50. They now have a "buy" rating on the stock.
4/16
03:11 am
vvos
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... [Yahoo! Finance]
High
Report
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... [Yahoo! Finance]
4/15
08:12 pm
vvos
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call [Yahoo! Finance]
High
Report
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call [Yahoo! Finance]
4/15
05:38 pm
vvos
Vivos Therapeutics Reports Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
Vivos Therapeutics Reports Full Year 2025 Financial Results [Yahoo! Finance]
4/15
04:20 pm
vvos
Vivos Therapeutics Reports Full Year 2025 Financial Results
High
Report
Vivos Therapeutics Reports Full Year 2025 Financial Results
4/15
08:45 am
vvos
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
High
Report
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
4/7
08:45 am
vvos
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Medium
Report
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
3/26
08:45 am
vvos
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
Medium
Report
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
3/17
08:45 am
vvos
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
Medium
Report
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
2/5
08:45 am
vvos
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Medium
Report
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies